Big Rounds, Big Bucks For Biotechs In 2015
This article was originally published in Start Up
Executive Summary
Gurnet Capital's $600 million commitment to Boston Pharmaceuticals Inc. caps what has been a banner year for huge private biotech financings. Boston Pharma's is the biggest private round of the year so far, but it has plenty of company.